News

K+N and Novo Nordisk invest in sustainable fuel

Healthcare giant Novo Nordisk is partnering with Kuehne+Nagel to drive the development of sustainable aviation fuel (SAF).

Novo Nordisk has the target of zero CO2 emissions from operations and transport by 2030, and the deployment of 12 million litres of SAF means the healthcare giant can replace fossil fuel for all K+N airfreight shipments in 2022, avoiding 30,000 tonnes of CO2 in direct emissions.

The logistics giant is supporting customers transitioning to a low carbon business model by providing solutions to reduce or avoid carbon emissions including investing in alternative aviation fuels.

With growing demand for low carbon shipping options, leading to an increase in the production, development and deployment of SAF, K+N is raising awareness of the use of sustainable fuels to reduce the environmental footprint of airfreight.

Yngve Ruud, Member of the Management Board of K+N responsible for Air Logistics, says, “I am pleased that with our global SAF solutions, customers can easily switch to low carbon air transport. It’s another step on the way to the "zero impact" goal and yet another signal for more sustainable fuel production and use globally.”

Dorethe Nielsen, Vice President of Corporate Environmental Strategy at Novo Nordisk, adds, “Our air freight accounts for most of our product distribution emissions as we provide life-saving medicines to patients around the world. We want to drive change in this area to help pave the way for other companies to also transition and cut emissions.”